Stockreport

iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors

iTeos Therapeutics, Inc.  (ITOS) 
PDF WATERTOWN, Mass. and GOSSELIES, Belgium, March 06, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneer [Read more]